SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-438949
Filing Date
2014-12-10
Accepted
2014-12-10 16:05:53
Documents
8
Period of Report
2015-01-27
Effectiveness Date
2014-12-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d822953ddef14a.htm DEF 14A 180036
2 GRAPHIC g822953g07d48.jpg GRAPHIC 2362
3 GRAPHIC g822953g11p26.jpg GRAPHIC 2364
4 GRAPHIC g822953g31o97.jpg GRAPHIC 2112
5 GRAPHIC g822953g37z02.jpg GRAPHIC 9990
6 GRAPHIC g822953g59v69.jpg GRAPHIC 11365
7 GRAPHIC g822953g80s27.jpg GRAPHIC 10899
8 GRAPHIC g822953g86s14.jpg GRAPHIC 6746
  Complete submission text file 0001193125-14-438949.txt   245251
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32954 | Film No.: 141278060
SIC: 8731 Services-Commercial Physical & Biological Research